| Awdur (Corfforaethol) | European Court of Justice, Information Service |
|---|---|
| Cyhoeddwr | European Court of Justice (ECJ) |
| Manylion y Gyfres | T-677/14 |
| Dyddiad Cyhoeddi | 2014 |
| Math o Gynnwys | Overview |
|
Summary: The General Court annuls in part the European Commission’s decision finding the existence of restrictive agreements and an abuse of a dominant position on the market for perindopril, a medicine used to treat hypertension and heart failure. The General Court confirms, however, that certain patent settlement agreements may be restrictive of competition by object. |
|
| Dolen Ffynhonnell | Link to Main Source http://curia.europa.eu/juris/documents.jsf?num=T-677/14 |
| Dolenni Cysylltiedig |
|
| Categorïau Pwnc | Business and Industry |
| Pwnc | Medicines | Medical Devices |
| Allweddeiriau | CJEU Judgments, Competition Law |
| Gwledydd / Rhanbarthau | Europe |
| Sefydliadau Rhyngwladol | European Union [EU] |